Calm/Storm Ventures

Calm/Storm Ventures, based in Vienna, Austria, has established itself as a leading super-early-stage digital health fund across Europe. The firm distinguishes itself with a highly specialized investment thesis, focusing intently on the burgeoning sectors of femtech and "tabootech"—innovations addressing often-stigmatized health issues. A core tenet of their strategy is also a strong commitment to backing female founders, positioning them as a crucial capital provider for diverse teams tackling critical health challenges.

The venture capital firm primarily targets pre-seed and seed-stage companies, aiming to be the inaugural institutional investor. Their investment philosophy is rooted in identifying and nurturing groundbreaking digital solutions that promise to revolutionize healthcare delivery and access. By concentrating on niche yet high-impact areas like women's health and mental well-being, Calm/Storm Ventures plays a pivotal role in bringing much-needed innovation to underserved patient populations and market segments.

In 2022, Calm/Storm Ventures notably announced a €25 million fund, underscoring their significant financial commitment to the digital health ecosystem. This capital enables them to provide substantial initial support to promising startups. To date, the firm has actively deployed this capital, making over 20 investments across various European countries, demonstrating their broad reach and active participation in the market. Their typical first cheque size ranges from approximately $270,000 to $810,000, reflecting their strategic intent to provide meaningful early-stage funding that can catalyze significant growth and development for their portfolio companies.

Calm/Storm Ventures goes beyond mere capital provision, offering strategic guidance, extensive industry networks, and hands-on operational support. This comprehensive approach helps their portfolio companies navigate the complexities of the digital health landscape, accelerate product development, and achieve market penetration. Their unique focus and supportive ecosystem make them a highly attractive partner for early-stage digital health startups, particularly those led by women or addressing sensitive health topics.